Pain Beliefs and Functional Performance After Cosmetic Limb Lengthening Using the Lengthening Over Nail (LON) Technique

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-50
SponsorIstanbul Aydın University

About this trial

This pilot observational study aims to examine the relationship between pain beliefs, pain intensity, and functional performance in individuals who have undergone cosmetic lower limb lengthening surgery using the Lengthening Over Nail (LON) technique.

Seventeen healthy male participants aged between 20 and 50 years who have undergone bilateral lower limb lengthening with the LON method will be included in the study. All evaluations will be performed during a face-to-face clinical visit at the fourth postoperative week.

Pain intensity will be assessed using the Visual Analog Scale (VAS). Pain beliefs will be evaluated using the Pain Beliefs Questionnaire. Functional performance will be measured with the 6-Minute Walk Test (6MWT).

The study aims to better understand how patients' beliefs about pain may influence their perceived pain level and physical performance after cosmetic limb lengthening surgery. Findings may contribute to improving postoperative rehabilitation planning and patient management.

Eligibility criteria

Qualifiers

Age between 20 and 50 years

Underwent bilateral lower extremity cosmetic lengthening surgery using the LON (Lengthening Over Nail) technique

Completed postoperative rehabilitation process

Attending routine clinical follow-up at postoperative week 4

Disqualifiers

History of orthopedic surgery other than lower extremity lengthening

Presence of neurological, rheumatologic, or systemic diseases affecting physical performance

Postoperative complications such as infection, pseudoarthrosis, or implant failure

Any condition preventing participation in physical assessment

Trial design

Treatments tested in this trial

  • Postoperative Functional and Pain Assessment

Treatment groups

58 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators